To evaluate the impact of zinc supplementation on the clinical recovery and
body weight of children with persistent diarrhoea, a randomized, double-bl
ind, controlled trial was conducted in 190 children with persistent diarrho
ea aged between 3 and 24 months. Children were randomly allocated to receiv
e either zinc (20 mg d(-1)) syrup with multivitamin (2 x RDA) or multivitam
in alone in three divided daily doses for 2 weeks. The trial was conducted
in a diarrhoeal disease hospital in Dhaka, Bangladesh. Duration until clini
cal recovery (d), impact on body weight and serum zinc level after 2 weeks
of zinc supplementation were recorded. The duration of illness was signific
antly reduced (33%) with zinc supplementation among children who were under
weight (less than or equal to 70% wt/age, p = 0.03). Supplemented male chil
dren also had a significant reduction (27%) in duration for recovery compar
ed with unsupplemented children (p = 0.05). From baseline to convalescence,
zinc-supplemented children maintained their serum zinc concentration (13.4
vs 13.6 mu mol l(-1)), whereas unsupplemented children had a decrease in s
erum zinc after the 2 weeks of diarrhoea (13.6 vs 11.8 mu mol l(-1), p < 0.
03). The mean body weight of the children in the supplemented group was mai
ntained (5.72 vs 5.70 kg, p = 0.62) during hospitalization, unlike that of
the control group, in which there was a reduction in body weight (5.75 vs 5
.67 kg, p = 0.05). Five children in the unsupplemented group and one child
in the zinc-supplemented group died during the 2 weeks of supplementation (
p = 0.06). Zinc supplementation in persistent diarrhoea significantly reduc
ed the length of the recovery period in malnourished children and prevented
a fall in body weight and serum zinc concentration, indicating that zinc i
s a beneficial therapeutic strategy in this high-risk childhood illness.